Redefining Postpartum Depression Treatment: The Clinical Potential of Zuranolone

被引：2
|
作者：
Nashwan, Abdulqadir J. [1 ,2 ]
Rehan, Syeda Tayyaba [3 ]
Imran, Laiba [3 ]
Abbas, Samina Ghulam [3 ]
Khan, Sara [4 ]
机构：
[1] Qatar Univ, Coll Hlth Sci, Dept Publ Hlth, QU Hlth, Doha, Qatar
[2] Hamad Med Corp, Doha, Qatar
[3] Dow Univ Hlth Sci, Karachi 74200, Pakistan
[4] Bahria Univ, Inst Profess Psychol, Karachi 75260, Pakistan
来源：
ASIAN JOURNAL OF PSYCHIATRY | 2024年 / 91卷
关键词：
D O I：
10.1016/j.ajp.2023.103849
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Zuranolone Treatment for Depression: Steady Progress in Mechanism-Focused Therapeutics?
    Pine, Daniel S.
    AMERICAN JOURNAL OF PSYCHIATRY, 2023, 180 (09): : 631 - 633
  • [32] Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression
    Meltzer-Brody, Samantha
    Gerbasi, Margaret E.
    Mak, Catherine
    Toubouti, Youssef
    Smith, Sarah
    Roskell, Neil
    Tan, Robin
    Chen, Shih-Yin
    Deligiannidis, Kristina M.
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 582 - 595
  • [33] Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions
    Dennis, Cindy-Lee
    Singla, Daisy R.
    Brown, Hilary K.
    Savel, Katarina
    Clark, Crystal T.
    Grigoriadis, Sophie
    Vigod, Simone N.
    DRUGS, 2024, : 645 - 659
  • [34] Antidepressant treatment response of postpartum depression: Clinical and genetic factors
    Martin-Santos, R.
    Gelabert, E.
    Plaza, A.
    Navarro, P.
    Navines, R.
    Ascaso, C.
    Garcia, C.
    Gratacos, M.
    Estivill, X.
    Esteve, L. L. Garcia
    EUROPEAN PSYCHIATRY, 2007, 22 : S43 - S43
  • [35] The efficacy and safety of Zuranolone for treatment of depression: A systematic review and meta-analysis
    Fayoud, Aya M.
    Orebi, Hisham Ahmed
    Elshnoudy, Iman Abdelhady
    Elsebaie, Mai Alaaeldin Temraz
    Elewid, Mariam Mahmoud Mohamed
    Sabra, Hamdy Khaled
    PSYCHOPHARMACOLOGY, 2024, 241 (07) : 1299 - 1317
  • [36] Concurrent Improvement of Depressive and Anxiety Symptoms in Patients With Postpartum Depression Treated With the Oral Neuroactive Steroid Zuranolone
    Deligiannidis, Kristina
    Werneburg, Brian
    Huang, Ming-Yi
    Suthoff, Ellison
    Lasser, Robert
    Gunduz-Bruce, Handan
    Acaster, Sarah
    Fridman, Moshe
    Bonthapally, Vijayveer
    Kanes, Stephen J.
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 229 - 230
  • [37] The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis
    Winslow, Mackenzie
    White, Emily
    Rose, Suzanne J.
    Salzer, Elijah
    Nemec, Eric C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (03) : 590 - 601
  • [38] The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis
    Cha, Danielle S.
    Kleine, Nicholas
    Teopiz, Kayla M.
    Di Vincenzo, Joshua D.
    Ho, Roger
    Galibert, Stephanie L.
    Samra, Amrita
    Zilm, Samuel P. M.
    Cha, Rebekah H.
    d'Andrea, Giacomo
    Gill, Hartej
    Ceban, Felicia
    Meshkat, Shakila
    Wong, Sabrina
    Le, Gia Han
    Kwan, Angela T. H.
    Rosenblat, Joshua D.
    Rhee, Taeho Greg
    Mansur, Rodrigo B.
    Mcintyre, Roger S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (01) : 5 - 14
  • [39] Improvement in HAMD-17 Subscale Scores With 14-Day Treatment Course of Zuranolone in Postpartum Depression: Results From the SKYLARK Study
    Deligiannidis, Kristina
    Bullock, Amy
    Kotecha, Mona
    Li, Sigui
    Maximos, Bassem
    Vera, Theresa
    OBSTETRICS AND GYNECOLOGY, 2023, 141 : 64S - 65S
  • [40] Postpartum depression: Interdisciplinary treatment
    Dorn A.
    Mautner C.
    Der Gynäkologe, 2018, 51 (2): : 94 - 101
12345